Follow
Marlies Vanden Bempt
Marlies Vanden Bempt
Postdoctoral researcher in the lab of Experimental Hematology
Verified email at kuleuven.be
Title
Cited by
Cited by
Year
A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling
J Qian, S Olbrecht, B Boeckx, H Vos, D Laoui, E Etlioglu, E Wauters, ...
Cell research 30 (9), 745-762, 2020
4332020
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
A Bassez, H Vos, L Van Dyck, G Floris, I Arijs, C Desmedt, B Boeckx, ...
Nature medicine 27 (5), 820-832, 2021
3692021
HOXA9 cooperates with activated JAK/STAT signaling to drive leukemia development
CE de Bock, S Demeyer, S Degryse, D Verbeke, B Sweron, O Gielen, ...
Cancer discovery 8 (5), 616-631, 2018
1012018
Cooperative enhancer activation by TLX1 and STAT5 drives development of NUP214-ABL1/TLX1-positive T cell acute lymphoblastic leukemia
MV Bempt, S Demeyer, M Broux, J De Bie, S Bornschein, N Mentens, ...
Cancer cell 34 (2), 271-285. e7, 2018
512018
Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia
M Broux, C Prieto, S Demeyer, M Vanden Bempt, L Alberti-Servera, ...
Blood, The Journal of the American Society of Hematology 134 (16), 1323-1336, 2019
402019
Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL
S Degryse, S Bornschein, CE de Bock, E Leroy, M Vanden Bempt, ...
Blood, The Journal of the American Society of Hematology 131 (4), 421-425, 2018
352018
Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC-and TPM3-ALK fusions is characterized by copy number gain of the rearranged …
JA van der Krogt, MV Bempt, JF Ferreiro, N Mentens, K Jacobs, U Pluys, ...
Haematologica 102 (9), 1605, 2017
352017
Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified
K Debackere, L Marcelis, S Demeyer, M Vanden Bempt, N Mentens, ...
Nature communications 12 (1), 3705, 2021
212021
Generation of the Fip1l1–Pdgfra fusion gene using CRISPR/Cas genome editing
M Vanden Bempt, S Demeyer, N Mentens, E Geerdens, CE De Bock, ...
Leukemia 30 (9), 1913-1916, 2016
152016
Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma
M Vanden Bempt, K Debackere, S Demeyer, Q Van Thillo, N Meeuws, ...
Blood, The Journal of the American Society of Hematology 140 (23), 2463-2476, 2022
132022
EML1–ABL1 Is Activated by Coiled-Coil-Mediated Oligomerization and Induces T-Cell Acute Lymphoblastic Leukemia or Myeloproliferative Disease in a Mouse Bone Marrow Transplant Model
MV Bempt, N Mentens, P Vandenberghe, J Cools, K De Keersmaecker
Hemasphere 2 (2), e32, 2018
32018
Dual targeting of EZH2 and Histone Deacetylases in hematological malignancies promotes transcriptional and metabolic deregulation leading to ferroptosis
A Veloso, T Slegers, J Schoenaker, S Demeyer, S Van den Bergh, ...
bioRxiv, 2024.03. 03.583195, 2024
2024
3001–ABERRANT MYCN OVEREXPRESSION DRIVES ONCOGENIC HIJACKING OF EZH2 AS A TRANSCRIPTIONAL ACTIVATOR IN PERIPHERAL T CELL LYMPHOMA.
MV Bempt, K Debackere, A Veloso, S Demeyer, T Slegers, Q Van Thillo, ...
Experimental Hematology 124, S51, 2023
2023
P1297: ABERRANT MYCN EXPRESSION DRIVES ONCOGENIC HIJACKING OF EZH2 AS A TRANSCRIPTIONAL ACTIVATOR IN PERIPHERAL T CELL LYMPHOMA
MV Bempt, K Debackere, S Demeyer, Q Van Thillo, N Meeuws, J Cools, ...
HemaSphere 6, 1182-1183, 2022
2022
THE NUP214-ABL1 FUSION COOPERATES WITH TLX1 IN THE DEVELOPMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
MV Bempt, CE de Bock, S Demeyer, R Vandepoel, N Mentens, ...
Haematologica 101, 27-27, 2016
2016
Use of CRISPR/Cas genome editing in Ba/F3 cells to generate the Fip1l1-Pdgfra and Nup214-Abl1 fusion genes
MV Bempt, CE de Bock, N Mentens, O Gielen, E Geerdens, S Demeyer, ...
Blood 124 (21), 3575, 2014
2014
FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T cell lymphoma, not otherwise specified
K Debackere, L Marcelis, S e Demeyer, MV Bempt, N Mentens, O Gielen, ...
The system can't perform the operation now. Try again later.
Articles 1–17